The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphoma

被引:28
作者
Hartmann, Sylvia [1 ,2 ]
Pluetschow, Annette [3 ,4 ]
Mottok, Anja [5 ,6 ,7 ,8 ]
Bernd, Heinz-Wolfram [9 ]
Feller, Alfred C. [9 ]
Ott, German [10 ]
Cogliatti, Sergio [11 ]
Fend, Falko [12 ]
Quintanilla-Martinez, Leticia [12 ]
Stein, Harald [13 ]
Klapper, Wolfram [14 ]
Moeller, Peter [15 ]
Rosenwald, Andreas [5 ,6 ]
Engert, Andreas [3 ,4 ]
Hansmann, Martin-Leo [1 ,2 ,16 ]
Eichenauer, Dennis A. [3 ,4 ]
机构
[1] Goethe Univ, Senckenberg Inst Pathol, Frankfurt, Germany
[2] Goethe Univ, Reference & Consultat Ctr Lymph Node & Lymphoma P, Frankfurt, Germany
[3] Univ Cologne, Ctr Integrated Oncol Aachen Bonn Cologne Dusseldo, Dept Internal Med 1, Cologne, Germany
[4] Univ Hosp Cologne, German Hodgkin Study Grp, Cologne, Germany
[5] Univ Wurzburg, Inst Pathol, Wurzburg, Germany
[6] Comprehens Canc Ctr CCC Mainfranken, Wurzburg, Germany
[7] Ulm Univ, Inst Human Genet, Ulm, Germany
[8] Ulm Univ, Med Ctr, Ulm, Germany
[9] Hematopathol Lubeck, Lubeck, Germany
[10] Robert Bosch Krankenhaus & Dr Margarete Fischer B, Dept Clin Pathol, Stuttgart, Germany
[11] Kantonsspital St Gallen, Inst Pathol, St Gallen, Switzerland
[12] Eberhard Karls Univ Tubingen, Inst Pathol, Tubingen, Germany
[13] Berlin Reference Ctr Lymphoma & Hematopathol, Pathodiagnost Berlin, Berlin, Germany
[14] Univ Hosp Schleswig Holstein, Hematopathol Sect & Lymph Node Registry, Inst Pathol, Campus Kiel, Kiel, Germany
[15] Univ Hosp Ulm, Inst Pathol, Ulm, Germany
[16] Frankfurt Inst Adv Studies, Frankfurt, Germany
关键词
PROGNOSTIC IMPACT; TRANSFORMATION; DISEASE;
D O I
10.1002/ajh.25607
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) can present with different histopathological growth patterns. The impact of these histopathological growth patterns on relapse characteristics is unknown. We therefore analyzed paired biopsies obtained at initial diagnosis and relapse from 33 NLPHL patients who had received first-line treatment within German Hodgkin Study Group (GHSG) trial protocols, and from a second cohort of 41 relapsed NLPHL patients who had been treated outside GHSG studies. Among the 33 GHSG patients, 21 patients presented with a typical growth pattern at initial diagnosis, whereas 12 patients had a variant histology. The histopathological growth patterns at initial diagnosis and at relapse were consistent in 67% of cases. A variant histology at initial diagnosis was associated with a shorter median time to lymphoma recurrence (2.8 vs 5.2 years; P = .0219). A similar tendency towards a shorter median time to lymphoma recurrence was observed for patients presenting with a variant histology at relapse, irrespective of the growth pattern at initial diagnosis. Results obtained from the 41 NLPHL patients who had been treated outside GHSG studies were comparable (median time to lymphoma recurrence for variant histology vs typical growth pattern at initial diagnosis: 1.5 vs 7.0 years). In conclusion, the histopathological growth pattern remains consistent at relapse in the majority of NLPHL cases, and has major impact on the time of relapse.
引用
收藏
页码:1208 / 1213
页数:6
相关论文
共 50 条
  • [31] EBV-positive nodular lymphocyte predominant Hodgkin lymphoma: a single institution experience
    Fei, Fei
    Kiruthiga, Kala Gnanasekaran
    Younes, Sheren
    Natkunam, Yasodha
    [J]. HUMAN PATHOLOGY, 2022, 129 : 32 - 39
  • [32] Nodular lymphocyte-predominant Hodgkin lymphoma in children: clinical course, biology, and management
    Gorde-Grosjean, Stephanie
    Guimard, Gregory
    Lambilliotte, Anne
    Coulomb-Lhermine, Aurore
    Montravers, Francoise
    Landman-Parker, Judith
    [J]. BULLETIN DU CANCER, 2014, 101 (09) : 881 - 890
  • [33] Intrafollicular classical Hodgkin lymphoma mimicking nodular lymphocyte predominant Hodgkin lymphoma: A report of two cases
    Tatsuno, Mai
    Maeshima, Akiko Miyagi
    Kim, Sung-Won
    Maruyama, Dai
    Taniguchi, Hirokazu
    Miyamoto, Ken-ichi
    Fukuhara, Suguru
    Kobayashi, Yukio
    Tobinai, Kensei
    Kushima, Ryoji
    [J]. PATHOLOGY INTERNATIONAL, 2014, 64 (12) : 613 - 617
  • [34] Nodular lymphocyte predominant Hodgkin lymphoma in Sweden between 2000 and 2014: an analysis of the Swedish Lymphoma Registry
    Molin, Daniel
    Linderoth, Johan
    Wahlin, Bjorn E.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2017, 177 (03) : 449 - 456
  • [35] Nodular lymphocyte predominant Hodgkin lymphoma may show a nodular pattern in which tumour cells do not invade the surrounding spaces
    Carbone, Antonino
    Gloghini, Annunziata
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2013, 163 (04) : 537 - 538
  • [36] Lymphocyte predominant cells of nodular lymphocyte predominant Hodgkin lymphoma interact with rosetting T cells in an immunological synapse
    Bein, Julia
    Thurner, Lorenz
    Hansmann, Martin-Leo
    Hartmann, Sylvia
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (12) : 1495 - 1502
  • [37] Histopathological and clinical features of nodular lymphocyte-predominant Hodgkin lymphoma and their impact on prognosis: first report from Iran
    Monabati, Ahmad
    Safaei, Akbar
    Mokhtari, Maral
    Nematollahi, Pardis
    Faghih, Marjan
    Boroumand-Noughabi, Samaneh
    [J]. JOURNAL OF HEMATOPATHOLOGY, 2020, 13 (03) : 143 - 152
  • [38] Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: a matched pair outcome analysis
    Xing, Katharine H.
    Connors, Joseph M.
    Lai, Anky
    Al-Mansour, Mubarak
    Sehn, Laurie H.
    Villa, Diego
    Klasa, Richard
    Shenkier, Tamara
    Gascoyne, Randy D.
    Skinnider, Brian
    Savage, Kerry J.
    [J]. BLOOD, 2014, 123 (23) : 3567 - 3573
  • [39] R-Bendamustine in the treatment of nodular lymphocyte-predominant Hodgkin lymphoma
    Prusila, Roosa Enni Inkeri
    Haapasaari, Kirsi-Maria
    Marin, Katja
    Pollari, Marjukka
    Soini, Ylermi
    Vornanen, Martine
    Karjalainen-Lindsberg, Marja-Liisa
    Turpeenniemi-Hujanen, Taina
    Kuittinen, Outi
    [J]. ACTA ONCOLOGICA, 2018, 57 (09) : 1265 - 1267
  • [40] CD15-expressing nodular lymphocyte-predominant Hodgkin lymphoma
    Venkataraman, Girish
    Raffeld, Mark
    Pittaluga, Stefania
    Jaffe, Elaine S.
    [J]. HISTOPATHOLOGY, 2011, 58 (05) : 803 - 805